Cartography Biosciences Funding: $124M Raised, Series B
Cartography Biosciences is a Biotech company based in Cambridge, MA. It has raised $124M in total funding. Latest round: Series B.
Cartography Biosciences funding overview
Cartography Biosciences is a Biotech company based in Cambridge, MA. Cartography Biosciences has raised $124M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2025. The round record for Cartography Biosciences runs through 2025; nothing later has been disclosed. Investors on record include 8VC, Andreessen Horowitz, Wing Venture Capital, Catalio Capital Management, ARTIS Ventures, Cancer Research Institute and 4 others. 10 distinct backers are named across the disclosed rounds.
Cartography Biosciences at a glance
Total raised
$124M
Latest round
Series B
Latest round date
September 2025
Industry
Biotech
Headquarters
Cambridge, MA
Notable investors
8VC, Andreessen Horowitz, Wing Venture Capital, Catalio Capital Management, ARTIS Ventures, Cancer Research Institute, Alexandria Real Estate Equities, Inc., AME Cloud Ventures
Frequently asked about Cartography Biosciences funding
How much has Cartography Biosciences raised?
Cartography Biosciences has raised $124M in total disclosed funding across the rounds on record.
Who has invested in Cartography Biosciences?
8VC, Andreessen Horowitz, Wing Venture Capital, Catalio Capital Management, ARTIS Ventures, Cancer Research Institute are named among the investors backing Cartography Biosciences.
What was the latest Cartography Biosciences funding round?
The most recent disclosed round is a Series B, announced in September 2025.
Where is Cartography Biosciences based?
Cartography Biosciences is based in Cambridge, MA.
What sector does Cartography Biosciences operate in?
Cartography Biosciences is tracked under Biotech from Cambridge, MA, with $124M in disclosed funding.
When did Cartography Biosciences last raise?
The last disclosed Cartography Biosciences round closed in September 2025 at Series B.
Round data for Cartography Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Cambridge and backer lists below.
